Personal information

Other IDs

Scopus Author ID: 57203131313

Activities

Collapse all

Education and qualifications (1)

University of Auckland: Auckland, NZ

2014-02 to 2015-02 | Master of Science (Molecular medicine and pathology)
Education
Source: Self-asserted source
Nooriyah Poonawala Lohani

Works (3)

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

JCI insight
2018 | Journal article
DOI: 10.1172/jci.insight.122204
EID:

2-s2.0-85062249490
Contributors: Jamieson, S.M.; Tsai, P.; Kondratyev, M.K.; Budhani, P.; Liu, A.; Senzer, N.N.; Chiorean, E.G.; Jalal, S.I.; Nemunaitis, J.J.; Kee, D. et al.
Source: Self-asserted source
Nooriyah Poonawala Lohani via Scopus - Elsevier

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

npj Genomic Medicine
2018 | Journal article
DOI: 10.1038/s41525-018-0058-3
EID:

2-s2.0-85050631559
Contributors: Lawrence, B.; Blenkiron, C.; Parker, K.; Tsai, P.; Fitzgerald, S.; Shields, P.; Robb, T.; Yeong, M.L.; Kramer, N.; James, S. et al.
Source: Self-asserted source
Nooriyah Poonawala Lohani via Scopus - Elsevier

Abstract 169: Preclinical efficacy and sensitivity determinants of evofosfamide in molecularly defined models of head and neck squamous cell carcinoma

Experimental and Molecular Therapeutics
2017-07-01 | Journal article
DOI: 10.1158/1538-7445.am2017-169
Source: Self-asserted source
Nooriyah Poonawala Lohani
How many people are using ORCID?